Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response

被引:69
作者
Kébaïer, C
Louzir, H
Chenik, M
Ben Salah, A
Dellagi, K
机构
[1] WHO, Collaborating Ctr Res & Training Immunol & Leishm, Inst Pasteur Tunis, Lab Immunol LAF301, Tunis 1002, Tunisia
[2] WHO, Collaborating Ctr Res & Training Immunol & Leishm, Inst Pasteur Tunis, Lab Epidemiol & Ecol Parasitaire, Tunis 1002, Tunisia
关键词
D O I
10.1128/IAI.69.8.4906-4915.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Virulence variability was investigated by analyzing the experimental pathogenicity of 19 Leishmania major strains in susceptible BALB/c mice. Twelve strains were isolated from Tunisian patients with zoonotic cutaneous leishmaniasis; seven strains were isolated in Syria (n = 1), Saudi Arabia (n = 2), Jordan (n = 2), or Israel (n = 2). BALB/c mice were injected in the hind footpad with 2 x 10(6) amastigotes of the various isolates, and lesion progression was recorded weekly for 9 weeks. Interleukin-4 (IL-4) and gamma interferon (IFN-gamma) production of lymph node mononuclear cells activated in vitro with parasite antigens were evaluated 5 weeks after infection. We show that disease progression induced by different L. major isolates was largely heterogeneous although reproducible results were obtained when using the same isolate. Interestingly, isolates from the Middle East induced a more severe disease than did the majority of Tunisian isolates. Strains with the highest virulence tend to generate more IL-4 and less IFN-gamma in vitro at week 5 postinfection as well as higher levels of early IL-4 mRNA in the lymph node draining the inoculation site at 16 h postinfection. These results suggest that L. major isolates from the field may differ in virulence, which influences the course of the disease induced in mice and the type of immune response elicited by the infected host.
引用
收藏
页码:4906 / 4915
页数:10
相关论文
共 59 条
[1]   Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/c mice [J].
Almeida, RP ;
BarralNetto, M ;
DeJesus, AMR ;
DeFreitas, LAR ;
Carvalho, EM ;
Barral, A .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1996, 54 (02) :178-184
[2]   ISOLATION OF LMCPC, A GENE ENCODING A LEISHMANIA-MEXICANA CATHEPSIN-B-LIKE CYSTEINE PROTEINASE [J].
BART, G ;
COOMBS, GH ;
MOTTRAM, JC .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1995, 73 (1-2) :271-274
[3]   A RANDOMIZED, PLACEBO-CONTROLLED TRIAL IN TUNISIA TREATING CUTANEOUS LEISHMANIASIS WITH PAROMOMYCIN OINTMENT [J].
BENSALAH, A ;
ZAKRAOUI, H ;
ZAATOUR, A ;
FTAITI, A ;
ZAAFOURI, B ;
GARRAOUI, A ;
OLLIARO, PL ;
DELLAGI, K ;
BENISMAIL, R .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 53 (02) :162-166
[4]   Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania [J].
Beverley, SM ;
Turco, SJ .
TRENDS IN MICROBIOLOGY, 1998, 6 (01) :35-40
[5]   Kinetics of entry of virulent and avirulent strains of Leishmania donovani into macrophages: A possible role of virulence molecules (gp63 and LPG) [J].
Chakrabarty, R ;
Mukherjee, S ;
Lu, HG ;
McGwire, BS ;
Chang, KP ;
Basu, MK .
JOURNAL OF PARASITOLOGY, 1996, 82 (04) :632-635
[6]  
Courret N, 1999, EUR J IMMUNOL, V29, P762, DOI 10.1002/(SICI)1521-4141(199903)29:03&lt
[7]  
762::AID-IMMU762&gt
[8]  
3.0.CO
[9]  
2-4
[10]   METACYCLOGENESIS IS A MAJOR DETERMINANT OF LEISHMANIA PROMASTIGOTE VIRULENCE AND ATTENUATION [J].
DASILVA, R ;
SACKS, DL .
INFECTION AND IMMUNITY, 1987, 55 (11) :2802-2806